Suchergebnis | Hamburg Open Science

Facetten

22 Einträge gefunden

Transcriptional behavior of the HIV-1 promoter in context of the BACH2 prominent proviral integration gene
2021 - Forschungsinformationssystem des UKE
The acidic protein rich in leucines Anp32b is an immunomodulator of inflammation in mice
2019 - Forschungsinformationssystem des UKE - frei zugänglich
Pinpointing recurrent proviral integration sites in new models for latent HIV-1 infection
2018 - Forschungsinformationssystem des UKE
Improving Lentiviral Transduction of CD34(+) Hematopoietic Stem and Progenitor Cells
2018 - Forschungsinformationssystem des UKE
CRISPR-Cas9-based Genome Engineering to Generate Jurkat Reporter Models for HIV-1 Infection with Selected Proviral Integration Sites
2018 - Forschungsinformationssystem des UKE
Assessment of the HIV-1 reservoir in CD4+ regulatory T cells by a Droplet Digital PCR based approach
2017 - Forschungsinformationssystem des UKE
Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems
2016 - Forschungsinformationssystem des UKE - frei zugänglich
Linker-region modified derivatives of the deoxyhypusine synthase inhibitor CNI-1493 suppress HIV-1 replication
2016 - Forschungsinformationssystem der UHH
Parallel assessment of Th17 cell frequencies by surface marker co-expression versus ex vivo IL-17 production in HIV-1 infection
2016 - Forschungsinformationssystem des UKE
CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X
2015 - Forschungsinformationssystem des UKE - frei zugänglich
mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5
2015 - Forschungsinformationssystem des UKE - frei zugänglich
In silico design, synthesis and screening of novel deoxyhypusine synthase inhibitors targeting HIV-1 replication
2014 - Forschungsinformationssystem der UHH
CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression
2014 - Forschungsinformationssystem des UKE - frei zugänglich
New disubstituted heteroaryl compound useful for treating a disease consisting of viral diseases, proliferative diseases, neurodegenerative diseases, diabetes, malaria, and HIV infection, Desoxyhypusin-Synthase-Inhibitoren
2013 - Forschungsinformationssystem der UHH
Die Deoxyhypusin-Synthase als ein mögliches Ziel für die Behandlung von Glioblastoma multiforme und die Rolle des eukaryotischen Translationsinitiationsfaktors eIF-5A2 in vivo
1. Preukschas, Michael
2. Hauber, Joachim
2013 - Forschungsinformationssystem der UHH - frei zugänglich
D(GGGT)4 and r(GGGU)4 are both HIV-1 inhibitors and interleukin-6 receptor aptamers
2013 - Forschungsinformationssystem der UHH
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.
2012 - Forschungsinformationssystem des UKE - frei zugänglich
Preventing fusarium head blight of wheat and cob rot of maize by inhibition of fungal deoxyhypusine synthase
2011 - Forschungsinformationssystem der UHH - frei zugänglich
Gene therapy strategies: can we eradicate HIV?
2011 - Forschungsinformationssystem des UKE
Rational drug design-screening and synthesis of potential deoxyhypusine synthase inhibitors targeting HIV-1 replication
2010 - Forschungsinformationssystem der UHH

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Transcriptional behavior of the HIV-1 promoter in context of the BACH2 prominent proviral integration gene

The acidic protein rich in leucines Anp32b is an immunomodulator of inflammation in mice

Pinpointing recurrent proviral integration sites in new models for latent HIV-1 infection

Improving Lentiviral Transduction of CD34(+) Hematopoietic Stem and Progenitor Cells

CRISPR-Cas9-based Genome Engineering to Generate Jurkat Reporter Models for HIV-1 Infection with Selected Proviral Integration Sites

Assessment of the HIV-1 reservoir in CD4+ regulatory T cells by a Droplet Digital PCR based approach

Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems

Linker-region modified derivatives of the deoxyhypusine synthase inhibitor CNI-1493 suppress HIV-1 replication

Parallel assessment of Th17 cell frequencies by surface marker co-expression versus ex vivo IL-17 production in HIV-1 infection

CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X

mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5

In silico design, synthesis and screening of novel deoxyhypusine synthase inhibitors targeting HIV-1 replication

CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression

New disubstituted heteroaryl compound useful for treating a disease consisting of viral diseases, proliferative diseases, neurodegenerative diseases, diabetes, malaria, and HIV infection, Desoxyhypusin-Synthase-Inhibitoren

Die Deoxyhypusin-Synthase als ein mögliches Ziel für die Behandlung von Glioblastoma multiforme und die Rolle des eukaryotischen Translationsinitiationsfaktors eIF-5A2 in vivo

D(GGGT)4 and r(GGGU)4 are both HIV-1 inhibitors and interleukin-6 receptor aptamers

Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.

Preventing fusarium head blight of wheat and cob rot of maize by inhibition of fungal deoxyhypusine synthase

Gene therapy strategies: can we eradicate HIV?

Rational drug design-screening and synthesis of potential deoxyhypusine synthase inhibitors targeting HIV-1 replication